RETRACTION: Zebularine Enhances Apoptosis of Human Osteosarcoma Cells by Suppressing Methylation of ARHI

IF 4.5 2区 医学 Q1 ONCOLOGY
Cancer Science Pub Date : 2024-09-16 DOI:10.1111/cas.16346
{"title":"RETRACTION: Zebularine Enhances Apoptosis of Human Osteosarcoma Cells by Suppressing Methylation of ARHI","authors":"","doi":"10.1111/cas.16346","DOIUrl":null,"url":null,"abstract":"<p><b>RETRACTION</b>: K. Ye, S. Wang, J. Wang, H. Han, B. Ma and Y. Yang, “Zebularine Enhances Apoptosis of Human Osteosarcoma Cells by Suppressing Methylation of ARHI,” <i>Cancer Science</i> 107, no. 12 (2016): 1851–1857, https://doi.org/10.1111/cas.13088.</p><p>The above article, published online on 29 September 2016 in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the journal Editor-in-Chief, Masanori Hatakeyama; the Japanese Cancer Association; and John Wiley &amp; Sons Australia, Ltd. The retraction has been agreed following an investigation into concerns raised by a third party, which revealed that the western blots presented in figure 4a and 4d contain duplicated bands. Furthermore, duplications were found between bands within figure 4d itself, some of which appear to have been horizontally flipped. The authors did not respond to the concerns raised and did not provide their original data. The editors consider the results and conclusion reported in this article unreliable.</p>","PeriodicalId":9580,"journal":{"name":"Cancer Science","volume":"115 12","pages":"4080"},"PeriodicalIF":4.5000,"publicationDate":"2024-09-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/cas.16346","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer Science","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/cas.16346","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

RETRACTION: K. Ye, S. Wang, J. Wang, H. Han, B. Ma and Y. Yang, “Zebularine Enhances Apoptosis of Human Osteosarcoma Cells by Suppressing Methylation of ARHI,” Cancer Science 107, no. 12 (2016): 1851–1857, https://doi.org/10.1111/cas.13088.

The above article, published online on 29 September 2016 in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the journal Editor-in-Chief, Masanori Hatakeyama; the Japanese Cancer Association; and John Wiley & Sons Australia, Ltd. The retraction has been agreed following an investigation into concerns raised by a third party, which revealed that the western blots presented in figure 4a and 4d contain duplicated bands. Furthermore, duplications were found between bands within figure 4d itself, some of which appear to have been horizontally flipped. The authors did not respond to the concerns raised and did not provide their original data. The editors consider the results and conclusion reported in this article unreliable.

返回:斑蝥素通过抑制 ARHI 的甲基化促进人骨肉瘤细胞凋亡
转载:K. Ye, S. Wang, J. Wang, H. Han, B. Ma and Y. Yang, "Zebularine Enhances Apoptosis of Human Osteosarcoma Cells by Suppressing Methylation of ARHI," Cancer Science 107, no:1851–1857, https://doi.org/10.1111/cas.13088.
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Cancer Science
Cancer Science 医学-肿瘤学
自引率
3.50%
发文量
406
审稿时长
2 months
期刊介绍: Cancer Science (formerly Japanese Journal of Cancer Research) is a monthly publication of the Japanese Cancer Association. First published in 1907, the Journal continues to publish original articles, editorials, and letters to the editor, describing original research in the fields of basic, translational and clinical cancer research. The Journal also accepts reports and case reports. Cancer Science aims to present highly significant and timely findings that have a significant clinical impact on oncologists or that may alter the disease concept of a tumor. The Journal will not publish case reports that describe a rare tumor or condition without new findings to be added to previous reports; combination of different tumors without new suggestive findings for oncological research; remarkable effect of already known treatments without suggestive data to explain the exceptional result. Review articles may also be published.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信